528 related articles for article (PubMed ID: 29485856)
1. SWATHtoMRM: Development of High-Coverage Targeted Metabolomics Method Using SWATH Technology for Biomarker Discovery.
Zha H; Cai Y; Yin Y; Wang Z; Li K; Zhu ZJ
Anal Chem; 2018 Mar; 90(6):4062-4070. PubMed ID: 29485856
[TBL] [Abstract][Full Text] [Related]
2. Novel high-coverage targeted metabolomics method (SWATHtoMRM) for exploring follicular fluid metabolome alterations in women with recurrent spontaneous abortion undergoing in vitro fertilization.
Song J; Wang X; Guo Y; Yang Y; Xu K; Wang T; Sa Y; Yuan L; Jiang H; Guo J; Sun Z
Sci Rep; 2019 Jul; 9(1):10873. PubMed ID: 31350457
[TBL] [Abstract][Full Text] [Related]
3. Development of a Correlative Strategy To Discover Colorectal Tumor Tissue Derived Metabolite Biomarkers in Plasma Using Untargeted Metabolomics.
Wang Z; Cui B; Zhang F; Yang Y; Shen X; Li Z; Zhao W; Zhang Y; Deng K; Rong Z; Yang K; Yu X; Li K; Han P; Zhu ZJ
Anal Chem; 2019 Feb; 91(3):2401-2408. PubMed ID: 30580524
[TBL] [Abstract][Full Text] [Related]
4. Development and application of time staggered/mass staggered-globally optimized targeted mass spectrometry.
Zhong F; Xu M; Zhu J
J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Jul; 1120():80-88. PubMed ID: 31071582
[TBL] [Abstract][Full Text] [Related]
5. Globally Optimized Targeted Mass Spectrometry: Reliable Metabolomics Analysis with Broad Coverage.
Gu H; Zhang P; Zhu J; Raftery D
Anal Chem; 2015 Dec; 87(24):12355-62. PubMed ID: 26579731
[TBL] [Abstract][Full Text] [Related]
6. Large-scale targeted metabolomics method for metabolite profiling of human samples.
Cao G; Song Z; Hong Y; Yang Z; Song Y; Chen Z; Chen Z; Cai Z
Anal Chim Acta; 2020 Aug; 1125():144-151. PubMed ID: 32674760
[TBL] [Abstract][Full Text] [Related]
7. Development of a universal metabolome-standard method for long-term LC-MS metabolome profiling and its application for bladder cancer urine-metabolite-biomarker discovery.
Peng J; Chen YT; Chen CL; Li L
Anal Chem; 2014 Jul; 86(13):6540-7. PubMed ID: 24877652
[TBL] [Abstract][Full Text] [Related]
8. Metabonomics of human colorectal cancer: new approaches for early diagnosis and biomarker discovery.
Ni Y; Xie G; Jia W
J Proteome Res; 2014 Sep; 13(9):3857-70. PubMed ID: 25105552
[TBL] [Abstract][Full Text] [Related]
9. Database-Assisted Globally Optimized Targeted Mass Spectrometry (dGOT-MS): Broad and Reliable Metabolomics Analysis with Enhanced Identification.
Shi X; Wang S; Jasbi P; Turner C; Hrovat J; Wei Y; Liu J; Gu H
Anal Chem; 2019 Nov; 91(21):13737-13745. PubMed ID: 31556994
[TBL] [Abstract][Full Text] [Related]
10. A quantitative multimodal metabolomic assay for colorectal cancer.
Farshidfar F; Kopciuk KA; Hilsden R; McGregor SE; Mazurak VC; Buie WD; MacLean A; Vogel HJ; Bathe OF
BMC Cancer; 2018 Jan; 18(1):26. PubMed ID: 29301511
[TBL] [Abstract][Full Text] [Related]
11. Reduced levels of hydroxylated, polyunsaturated ultra long-chain fatty acids in the serum of colorectal cancer patients: implications for early screening and detection.
Ritchie SA; Ahiahonu PW; Jayasinghe D; Heath D; Liu J; Lu Y; Jin W; Kavianpour A; Yamazaki Y; Khan AM; Hossain M; Su-Myat KK; Wood PL; Krenitsky K; Takemasa I; Miyake M; Sekimoto M; Monden M; Matsubara H; Nomura F; Goodenowe DB
BMC Med; 2010 Feb; 8():13. PubMed ID: 20156336
[TBL] [Abstract][Full Text] [Related]
12. Targeted serum metabolite profiling and sequential metabolite ratio analysis for colorectal cancer progression monitoring.
Zhu J; Djukovic D; Deng L; Gu H; Himmati F; Abu Zaid M; Chiorean EG; Raftery D
Anal Bioanal Chem; 2015 Oct; 407(26):7857-63. PubMed ID: 26342311
[TBL] [Abstract][Full Text] [Related]
13. A large-scale and robust dynamic MRM study of colorectal cancer biomarkers.
You J; Kao A; Dillon R; Croner LJ; Benz R; Blume JE; Wilcox B
J Proteomics; 2018 Sep; 187():80-92. PubMed ID: 29953963
[TBL] [Abstract][Full Text] [Related]
14. A Simultaneous Metabolic Profiling and Quantitative Multimetabolite Metabolomic Method for Human Plasma Using Gas-Chromatography Tandem Mass Spectrometry.
Savolainen OI; Sandberg AS; Ross AB
J Proteome Res; 2016 Jan; 15(1):259-65. PubMed ID: 26615962
[TBL] [Abstract][Full Text] [Related]
15. Analytical considerations for (un)-targeted metabolomic studies with special focus on forensic applications.
Boxler MI; Schneider TD; Kraemer T; Steuer AE
Drug Test Anal; 2019 May; 11(5):678-696. PubMed ID: 30408838
[TBL] [Abstract][Full Text] [Related]
16. Strategies for large-scale targeted metabolomics quantification by liquid chromatography-mass spectrometry.
Zhou J; Yin Y
Analyst; 2016 Nov; 141(23):6362-6373. PubMed ID: 27722450
[TBL] [Abstract][Full Text] [Related]
17. Multiple reaction monitoring-ion pair finder: a systematic approach to transform nontargeted mode to pseudotargeted mode for metabolomics study based on liquid chromatography-mass spectrometry.
Luo P; Dai W; Yin P; Zeng Z; Kong H; Zhou L; Wang X; Chen S; Lu X; Xu G
Anal Chem; 2015; 87(10):5050-5. PubMed ID: 25884293
[TBL] [Abstract][Full Text] [Related]
18. Ion-Pair Selection Method for Pseudotargeted Metabolomics Based on SWATH MS Acquisition and Its Application in Differential Metabolite Discovery of Type 2 Diabetes.
Wang L; Su B; Zeng Z; Li C; Zhao X; Lv W; Xuan Q; Ouyang Y; Zhou L; Yin P; Peng X; Lu X; Lin X; Xu G
Anal Chem; 2018 Oct; 90(19):11401-11408. PubMed ID: 30148611
[TBL] [Abstract][Full Text] [Related]
19. Methods used to increase the comprehensive coverage of urinary and plasma metabolomes by MS.
Chen Y; Xu J; Zhang R; Abliz Z
Bioanalysis; 2016 May; 8(9):981-97. PubMed ID: 27079429
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
